Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Natural history of atypical parkinsonian syndromes: a multi-center observation

Official title: Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)

Run by Second Affiliated Hospital of Soochow University · NCT07805967 · Data updated 2026-11-12

This study follows people with APS like MSA, DLB, PSP, and CBD to see how their symptoms and brain images change over time.

More Multiple System Atrophy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorSecond Affiliated Hospital of Soochow University
Academic / other
Locations20 sites (Changshu, Jiangsu and 19 other locations)
StatusRecruiting
StartedNovember 12, 2025
Main results expectedAugust 31, 2030
Study endsAugust 31, 2030
Registry record updatedSeptember 8, 2026
Trial IDNCT07805967 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with probable MSA, probable DLB, probable PSP-Richardson syndrome, or probable CBD diagnosed within the past three years (MSA) or meeting respective diagnostic criteria, able to undergo serial assessments and imaging.

Probably not a fit

Patients who already have advanced disease beyond early stages or who are unable to participate in serial follow-up may derive little direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, multi-center study aimed at detailing how motor and non-motor symptoms progress in atypical parkinsonian syndromes. Researchers will document clinical features and imaging patterns to create a comprehensive assessment framework. The project builds clinical and biological databases to identify biomarkers that may predict disease trajectory. No experimental treatments are given; data collection is purely observational. Participants are followed over time to characterize the natural history of these conditions.

Why it matters

Potential benefit: Successful completion could improve understanding of progression and help identify biomarkers for earlier and more accurate prognosis.

How similar studies have gone: Previous observational efforts in APS have yielded valuable natural history data and biomarker insights, though this study adds multi-center data and standardized assessment frameworks.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. MSA : Meets the "probable MSA" criteria in the 2022 Chinese expert consensus on MSA diagnosis (MSA-P or MSA-C subtype); disease duration ≤3 years (from onset of first motor symptoms) .
2. DLB : Meets "probable DLB" criteria per the 2017 McKeith diagnostic criteria; MMSE ≥18 (to exclude severe dementia confounding assessment) .
3. PSP : Meets "probable PSP-Richardson syndrome" criteria per the 2017 PSP diagnostic standards; vertical gaze palsy or postural instability with duration ≤2 years .
4. CBD : Meets "probable CBD" criteria per the 2019 Chinese expert consensus on corticobasal degeneration diagnosis and treatment; asymmetric cortical symptoms (apraxia/dystonia/alien limb).

Exclusion Criteria:

1. Parkinson's disease , spinocerebellar ataxia (SCA) and other secondary autonomic failure .
2. Vascular parkinsonism , Parkinsonism caused by stroke , tumor , or immune-mediated encephalitis .

Where it's running

  • Changshu Hospital Affiliated to Nanjing University of Chinese Medicine
    Changshu, Jiangsu, China
    Recruiting
  • Jiangsu Province (Suqian) Hospital
    Suqian, Jiangsu, China
    Recruiting
  • The Forth Affiliated Hospital of Soochow University
    Suzhou, Jiangsu, China
    Recruiting
  • The Second Affiliated Hospital of Soochow University
    Suzhou, Jiangsu, China
    Recruiting
  • Yancheng Third People's Hospital
    Yancheng, Jiangsu, China
    Recruiting
  • The Forth People's Hospital of Zhenjiang
    Zhenjiang, Jiangsu, China
    Recruiting
Show 14 more locations
  • The second People's Hospital of Huai'an
    Huai'an, Jiangsu, China
    Not yet recruiting
  • The First People's Hospial of Kunshan
    Kunshan, Jiangsu, China
    Not yet recruiting
  • Jiangsu Province Official Hospital
    Nanjing, Jiangsu, China
    Not yet recruiting
  • The Second Affiliated Hospital of Nantong University
    Nantong, Jiangsu, China
    Not yet recruiting
  • The Second Affiliated Hospital of Xuzhou Medical University
    Xuzhou, Jiangsu, China
    Not yet recruiting
  • Affiliated Hospital of Yangzhou University
    Yangzhou, Jiangsu, China
    Not yet recruiting
  • Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine/Zhangjiagang Traditional Chinese Medicine Hospital
    Zhangjiagang, Jiangsu, China
    Not yet recruiting
  • Yantai Yuhuangding Hospital
    Yantai, Shandong, China
    Not yet recruiting
  • Mianyang 404 Hospital
    Mianyang, Sichuan, China
    Not yet recruiting
  • Jiaxing Second Hospital
    Jiaxing, Zhejiang, China
    Not yet recruiting
  • Deyang People's Hospital
    Deyang, China
    Not yet recruiting
  • Changxing people' s hospital
    Huzhou, China
    Not yet recruiting
  • Affiliated Hospital of Nantong University
    Nantong, China
    Not yet recruiting
  • The Affiliated Hospital of Xuzhou Medical University
    Xuzhou, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Genetic program for Progressive Supranuclear Palsy and related conditions

    This study is collecting DNA from adults with Progressive Supranuclear Palsy and similar conditions to see how genetics might help improve diagnosis and care for patients.

    Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06647641

  • Synaptic Loss in Multiple System Atrophy

    This study looks at how losing connections between brain cells affects people with multiple system atrophy.

    Recruiting University of Exeter · Exeter · NCT05121012

  • Longitudinal study of frontotemporal lobar degeneration

    This study is trying to learn more about frontotemporal lobar degeneration by following both affected individuals and their family members over time to see how the condition develops.

    Recruiting at 25 sites Mayo Clinic · Birmingham, Alabama and 25 other locations · NCT04363684

  • Tributyrin for PSP: a virtual, early-phase study

    This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.

    Recruiting Phase 1/2 University of Michigan · Ann Arbor, Michigan · NCT07863180

  • Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases

    This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.

    Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07798700

  • Longitudinal registry of people with multiple system atrophy in China

    This study follows Chinese patients with multiple system atrophy over time to describe how the disease starts and progresses and to compare with people with Parkinson's and healthy controls.

    Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07644013

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.